Search Results
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC
Advances in Immunotherapy & Resectable Non-Small Cell Lung Cancer
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
From concept to indication: Neoadjuvant immunotherapy for operable lung cancer
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Improve Outcomes?
Pathologic Response After Neoadjuvant Immunotherapy: Facilitating Progress in Early-Stage Cancers
Drs. Altorki & Spicer discuss immunotherapy advances in stage I-III NSCLC: https://bit.ly/3HVzzoZ
50th ICON | Lung Session
The role of surgery in early-stage NSCLC management | Jessica Donington
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy
Watch Prof. Solange Peters, MD, PhD, Mark M. Awad, MD, PhD, and Jonathan D. Spicer, MD, PhD, FRCS…
